ORSIRO
LIVE

Serial Number

79164728

Owner

Biotronik AG

Attorney

Jennifer Fraser

Filing Date

Dec 1, 2014

Add to watchlist:

No watchlists yet
View on USPTO

ORSIRO Trademark

Serial Number: 79164728 • Registration: 4879106

ORSIRO is a trademark filed by Biotronik AG on December 1, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Biotronik AG (50 trademarks)

Ackerstrasse 6
Bülach CH-8180 , CH

Entity Type: 99

Trademark Details

Filing Date

December 1, 2014

Registration Date

January 5, 2016

Published for Opposition

October 20, 2015

Goods & Services

[ Surgical and ] medical apparatus and instruments, namely, [ vascular and ] cardiovascular implants consisting of artificial materials [ and surgical instruments; ] catheters; catheters for percutaneous transluminal coronary angioplasty (PTCA catheters) [ and catheters for percutaneous translumial angioplasty (PTA catheters), ] namely, balloon dilatation catheters; medical apparatus and instruments, namely, balloon catheters and stents; stents which can expand by means of balloons; [ self-expanding stents; ] drug-eluting stents [ ; absorbable stents; absorbable drug-eluting stents ]

[ Chemical and pharmaceutical preparations for medical use, namely, medicated polymer-based preparations, including limus preparations of polyester, polylactic limus preparations and inorganic preparations for the treatment of cardiovascular and vascular diseases; chemical and pharmaceutical preparations for medical use for improving the biocompatibility of implants, namely, the coating of stents; chemical and pharmaceutical preparations for medical use for improving the healing of implants, namely, medicated stents; chemical products for pharmaceutical use, namely, medicated polymer-based preparations for the treatment of cardiovascular and vascular diseases; chemical and pharmaceutical preparations for cardiovascular and vascular procedures; drugs for medical use, namely, medicines belonging to the family of limus, namely, derivatives of limus, sirolimus, rapamycin, everolimus, biolimus A9, zotarolimus, tacrolimus and pimecrolimus for the treatment of cardiovascular and vascular diseases; medicines for human use for use in cardiovascular and vascular procedures ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Apr 27, 2026 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 27, 2026 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 20, 2026 APRE
TEAS SECTION 71 & 15 RECEIVED
Dec 23, 2025 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Aug 7, 2025 NREP
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jan 5, 2025 REM4
INTERNATIONAL REGISTRATION RENEWED
Nov 28, 2024 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Mar 28, 2023 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 24, 2023 INPS
INVALIDATION PROCESSED
Feb 24, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 5, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 5, 2022 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
May 5, 2022 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 5, 2022 APRE
TEAS SECTION 71 RECEIVED
Oct 5, 2021 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Jun 5, 2021 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 5, 2021 REM3
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Apr 19, 2018 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Mar 9, 2018 CRCV
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 12, 2017 TCCA
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 16, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 6, 2016 FICS
FINAL DISPOSITION PROCESSED
Apr 6, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 5, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 5, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2015 NPUB
PUBLISHED FOR OPPOSITION
Oct 20, 2015 PUBO
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 2, 2015 TCCA
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 30, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 16, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 1, 2015 CRFA
ASSIGNED TO LIE
Aug 24, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 5, 2015 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jul 23, 2015 NREP
REFUSAL PROCESSED BY IB
Jun 7, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 21, 2015 RFCS
REFUSAL PROCESSED BY MPU
May 21, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 21, 2015 RFCR
NON-FINAL ACTION WRITTEN
May 20, 2015 CNRT
APPLICATION FILING RECEIPT MAILED
May 16, 2015 MAFR
ASSIGNED TO EXAMINER
May 12, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 12, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 7, 2015 REPR